Diabetes Mellitus Type 2 Clinical Trials

ReadTheTrial indexes 20 studies for Diabetes Mellitus Type 2. The most common development stage is N/A (10 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

20 clinical trials found for Diabetes Mellitus Type 2.

Pipeline by Phase

PhaseTrialsDistribution
N/A 10
50%
Phase 3 5
25%
Phase 4 3
15%
Phase 1 2
10%

Trial Status Breakdown

Trials for Diabetes Mellitus Type 2

Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. Once Weekly Versus Placebo in Children and Adolescents With Type 2 Diabetes

NCT07282613 · NOT YET RECRUITING · Phase 3

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

NCT07428746 · NOT YET RECRUITING · Phase 3

A Phase 4, Open-Label, Single-Arm, 46-Week Study to Investigate the Safety and Efficacy With Tirzepatide in Adult Indian Participants With Either Type 2 Diabetes or Obesity

NCT07438444 · NOT YET RECRUITING · Phase 4

Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes

NCT07375797 · RECRUITING · N/A

A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus

NCT07299084 · RECRUITING · Phase 1

Open-label, Double-arm, Controlled, Randomized, Multicentre Clinical Trial to Evaluate the Impact of Pharmacogenetic-guided Treatment in Patients With Insufficiently Controlled Type 2 Diabetes.

NCT06851962 · ACTIVE NOT RECRUITING · Phase 4

EASi-PROTKT™ - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Type 2 Diabetes, Hypertension and Established Cardiovascular Disease

NCT07064473 · RECRUITING · Phase 3

Evaluation of Autologous Adipose-Derived Stromal Vascular Fraction Obtained by 1210-nm Laser Photostimulation for the Treatment of Type 2 Diabetes Mellitus

NCT07487467 · RECRUITING · N/A

Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims Data

NCT06914154 · COMPLETED · N/A

Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction

NCT06914141 · COMPLETED · N/A

Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) 1.0 mg/1.0 mg s.c. Once Weekly Versus Tirzepatide 5 mg s.c. Once Weekly in Participants With Type 2 Diabetes Inadequately Controlled on Metformin, SGLT2 Inhibitor or Both

NCT06534411 · ACTIVE NOT RECRUITING · Phase 3

Effect of CagriSema, Semaglutide and Cagrilintide on Insulin Sensitivity and Pancreatic Endocrine Function in Adults With Type 2 Diabetes

NCT06403761 · COMPLETED · Phase 1

A Randomized Comparison of Cleerly Coronary Artery Disease Stage-Based Care Versus Risk Factor-Based Care for Primary Prevention of Cardiovascular Events

NCT06112418 · RECRUITING · N/A

Real-Time Glucose Monitoring Using FreeStyle Libre 3 in Adults With Type 2 Diabetes On Basal Insulin Plus SGLT2 Inhibitor and/or GLP-1

NCT05944432 · ACTIVE NOT RECRUITING · N/A

Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes Mellitus - The Meal Box Study

NCT05330247 · ACTIVE NOT RECRUITING · N/A

Efficacy and Safety of Oral Semaglutide Versus Placebo Both in Combination With Metformin and/or Basal Insulin in Children and Adolescents With Type 2 Diabetes

NCT04596631 · COMPLETED · Phase 3

Surgical or Medical Treatment for Pediatric Type 2 Diabetes

NCT04128995 · ACTIVE NOT RECRUITING · Phase 4

Gastric Emptying in Non-diabetic Individuals With Black African/Caribbean Heritage - Implications for the Pathogenesis of Type 2 Diabetes

NCT03864562 · COMPLETED · N/A

The Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination on Endothelial Function, Arterial Stiffness and Left Ventricular Deformation in Patients With Type 2 Diabetes With High Cardiovascular Risk

NCT03878706 · RECRUITING · N/A

EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) Study Program

NCT03363464 · ACTIVE NOT RECRUITING · N/A

Frequently Asked Questions

What clinical trials are available for Diabetes Mellitus Type 2?

There are 20 clinical trials listed for Diabetes Mellitus Type 2. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Diabetes Mellitus Type 2 trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Diabetes Mellitus Type 2 trials in?

Current Diabetes Mellitus Type 2 trials are distributed across: N/A (10), Phase 3 (5), Phase 4 (3), Phase 1 (2).

Find More Trials